What factors contribute to resistance to BCMA-targeted CAR T-cell therapies in multiple myeloma?
During the EHA-EBMT 6th European CAR T-cell Meeting, the Multiple Myeloma Hub spoke to Paola Neri, University of Calgary, Calgary, CA. We asked, What factors contribute to resistance to BCMA-targeted CAR T-cell therapies in multiple myeloma?